President's Budget Proposes Crack Down On 180-Day Generic Exclusivity Parking

February 12, 2018
The White House is taking on what it views as anticompetitive behavior by some generic drug companies that stave off additional generic entrants by being first to file and then “parking” exclusivity by failing to market their product. Cracking down on this practice will save the government $1.78 billion between 2019 and 2028, according to the White House's fiscal 2019 budget, released Monday (Feb. 12). Under the newly released budget, the White House proposes allowing FDA to tentatively approve a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.